Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-18-018906

Options or other derivatives

  • Chief Scientific Officer acquired 160,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sofia Michael J. Chief Scientific Officer 2018-04-16 Grant or award · Employee Stock Option (Right to Buy) +160,000 160,000 D
Loading xslF345X03/doc1.xml…